Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Download PDF


View Table of Contents

Therapies for Axial Disease in Psoriatic Arthritis. A Systematic Review

PETER NASH

ABSTRACT.

Prevalence rates for axial involvement in psoriatic arthritis (PsA) vary from 40% to 74% depending upon criteria for diagnosis. In the absence of trial evidence to assess axial involvement in PsA, the GRAPPA group, by consensus, has suggested that outcome measures and therapies for axial disease in ankylosing spondylitis (AS) be used. This systematic review addresses the management of axial disease in PsA, and provides treatment recommendations based on the AS literature. (First Release May 15 2006; J Rheumatol 2006;33:1431–4)

Key Indexing Terms:

ANKYLOSING SPONDYLITIS
PSORIATIC ARTHRITIS
AXIAL DISEASE

SPONDYLOARTHROPATHY
PSORIASIS
ANTIRHEUMATIC THERAPY


From the Department of Medicine, University of Queensland, Cotton Tree, Australia.

P. Nash, MBBS (Hons), FRACP.

Address reprint requests to Dr. P. Nash, Department of Medicine, University of Queensland, PO Box 59, Cotton Tree, Australia. E-mail: pnash@tpg.com.au




Return to July 2006 Table of Contents



© 2006. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.